Added to YB: 2021-02-09
Pitch date: 2021-02-09
APVO [bullish]
Aptevo Therapeutics Inc.
-100%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Company Info
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.
Market Cap
$2.2M
Pitch Price
$1.4M
Price Target
50.00 (+4325%)
Dividend
N/A
EV/EBITDA
0.05
P/E
-0.02
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
Aptevo Therapeutics: Positive Trial Results, Tang Capital Offer, Proxy Fight
APVO: Tang Capital acquired 42.5% stake after positive APVO436 trial data (2 complete remissions). Then offered $50/share for remaining co. Mgmt adopted poison pill. Tang (life-sci expert) launching proxy fight to join board & force sale. Royalty streams from Ruxience & IXINITY could be valuable. High risk/reward.
Read full article (4 min)